Mobi724 Global Solutions Inc. Signs MOU with First Global Data
Momentum Public Relations
Press Release: October 31, 2017
MONTREAL, Oct. 31, 2017 (GLOBE NEWSWIRE) — Mobi724 Global Solutions Inc. (“MOBI724” or the “Company”) (CSE:MOS) (OTCQB:MOBIF)- a Fintech leader offering all in one fully integrated EMV payment, card link couponing and digital marketing solutions, announces that it has entered into a Memorandum of Understanding with First Global Data Limited (“First Global”) (TSX-Venture:FGD) (Frankfurt Stock Exchange:1G5) for the deployment of First Global’s alternative payment service in the Philippines and targeted countries in Latin America.
First Global is a Fintech company with proprietary leading edge technology that enables the convergence of compliant domestic and cross border payments, shopping, Peer to Peer (“P2P”), Business to Consumer (“B2C”), and Business to Business (“B2B”) payments.
The anticipated parameters of the going forward relationship for the deployment of the alternative payment service are as follows:
- Mobi724 will leverage its base of customers to cross sell and to offer remittance payout services through Point of Sales connected to Mobi724’s payment gateway and a mobile wallet.
- First Global will integrate its platform with Mobi724’s payment gateway to provide a unique compliant trans-border system with a mobile wallet platform in the target countries, thus adding new payment capabilities for Mobi724’s acquirers and their respective merchants.
- Mobi724 will provide cash access flexibility via the mobile wallet which will include cash load and bills payment domestically in the target countries.
- First Global will customize an on-boarding experience for Mobi724’s customers.
- Revenues are expected to be shared between Mobi724 and First Global on a 50/50 per transaction basis.
- Final deal terms and conditions will be outlined in the definitive agreement prior to the companies launching the service.
The companies are working together towards the conclusion of a definitive agreement and expect completion of the first phase before the end of Q4, 2017.
“As we continue to gain momentum in the Philippines and LATAM, we believe that the addition of these value-added alternative payment solutions to our pipeline will increase revenues and complete our offering. Partnering with global innovators, such as First Global Data, is part of our growth strategy and has served us well in the past.” says CEO of Mobi724 – Marcel Vienneau
“Mobi724 has significant penetration in the Philippines and Latin America including key strategic relationships with banks. The objective is for First Global and Mobi724 to provide alternative payment solutions for these target banks and to facilitate cross-border remittances and payments inbound and domestically within these countries. The Philippines and Latin America are existing and active corridors for First Global, and we view this relationship with Mobi724 as an accelerator to drive incremental transactional growth, while at the same time being a major contributor to our global strategy,” says Andre Itwaru, Chairman and CEO of First Global Data Limited.
ABOUT First Global Data Ltd. (www.firstglobaldata.com)
First Global is an international financial services technology (“FINTECH”) company. First Global’s two main lines of business are mobile payments and cross border payments. First Global’s proprietary leading edge technology enables the convergence of compliant domestic and cross border payments, shopping, Peer to Peer (“P2P”), Business to Consumer (“B2C”), and Business to Business (“B2B”) payments. First Global enables its strategic partners and clients around the world with our leading edge financial services technology platform.
Mobi724 Global Solutions Inc. (www.mobi724.com)
MOBI724, a leader in the fintech industry based in Montreal (Canada), offers a unique and fully integrated suite of payment & digital marketing solutions with a combined EMV Payment, Card Linked Offers, and Digital Marketing platform that works on any card and any Mobile device. MOBI724’s solutions add value to all types of transactions benefiting banks, retailers and cardholders by leveraging available user and purchasing data to increase transaction volumes and spend. MOBI724 provides a turnkey solution to its clients to capture card transactions on any Mobile device, at any point of sale or from any payment card. MOBI724 provides its customers with full and comprehensive traceability and enriched consumer data through its offering. Its solutions enable card associations, retailers, manufacturers, offer providers, Mobile operators and card issuers to create, manage, deliver and “track and measure” incentive campaigns worldwide to any Mobile device and allow its redemption at any point of sales.
Forward-Looking Statements
Certain statements in this document, including those which express management’s expectations or estimations with regard to the Company’s future performance, constitute “forward-looking statements” as understood by applicable securities laws. Forward-looking statements are, of necessity, based on a certain number of estimates and hypotheses; while management considers these to be accurate at the time they are expressed, they are inherently subject to significant uncertainties and risks on the commercial, economic and competitive levels. We advise readers that these forward-looking statements are subject to risks, uncertainties, and other known and unknown factors that may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied in these forward-looking statements. Investors are advised to not rely unduly on the forward-looking statements. This advisory applies to all forward-looking statements, whether expressed orally or in writing, attributed to the Company or to any individual expressing them in the name of the Company. Unless required by law, the Company is under no obligation to publicly update these forward-looking statements, whether to reflect new information, future events, or other circumstances.
This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.
The Canadian Securities Exchange (CSE) has not reviewed this news release and does not accept responsibility for its adequacy or accuracy.
Contacts:
MOBI724 Global Solutions Inc.
Marcel Vienneau
1-514-394-5200 x 413
www.MOBI724.com
- Published in Mobi724 Global Solutions, Mobile Technology, News Home, Technology
IIROC Trade Halt – Puma Exploration Inc.
Momentum Public Relations
Press Release: October 31, 2017
Vancouver, British Columbia–(Newsfile Corp. – October 31, 2017) – The following issues have been halted by IIROC:
Company: | Puma Exploration Inc. |
TSX-V Symbol: | PUM |
Reason: | At the Request of the Company Pending News |
Halt Time (ET) | 09:12 |
IIROC can make a decision to impose a temporary suspension of trading in a security of a publicly listed company, usually in anticipation of a material news announcement by the company. Trading halts are issued based on the principle that all investors should have the same timely access to important company information. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.
– 30 –
For further information: IIROC Inquiries 1-877-442-4322 (Option 3) – Please note that IIROC is not able to provide any additional information regarding a specific trading halt. Information is limited to general enquiries only.
- Published in Mining, News Home, Puma Exploration
Auxico Announces Encouraging Metallurgical Results for the Campanillas Mine
Momentum Public Relations
Press Release: October 31, 2017
MONTREAL, Oct. 31, 2017 (GLOBE NEWSWIRE) — Auxico Resources Canada Inc. (CSE:AUAG) is pleased to announce encouraging metallurgical results from a 2.095 kg sample (2,095 g) taken from the volcanic breccia hostrock material in the footwall of the Campanillas Mine, which is located in the north-east corner of the Zamora Property. The sample contains 1.98 kg/t of silver (1,980 g/t) and 2.01 g/t of gold. This sample was treated by the Centre for Mineral Technology and Plastics in Thetford Mines in order to optimize the metallurgical extraction of both gold and silver. The recovery of gold was 71.60{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} and 92.9{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} for silver, as a result of processing this material by gravity and flotation methods. Please refer to the table below:
Metallurgical results – Campanillas | |||||||
Process | Gold | Silver | |||||
Gravity feed | 2.01 g/t | 1,980 g/t | |||||
Gravity concentrate | 8.12 g/t | 5,000 g/t | |||||
Flotation concentrate | 11.9 g/t | 6,854 g/t | |||||
Recovery by gravity | 13.8 {92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} | 8.6{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} | |||||
Recovery by flotation | 67.8{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} | 89.1{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} | |||||
Total Recovery | 71.60{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} | 92.9{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} |
The gravity concentrate represents 3.41{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} of the overall weight of the sample while the flotation concentrate represented 12.2{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} of the overall weight. Therefore, 92.9{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} of the silver and 71.6{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} of the gold were recovered from less than 13{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} of the overall weight of the feed material. The concentrates represent a concentration ratio of 8:1 with concentrates having a value of over USD 4,000 per tonne.
The sample was selected by the QP in the Campanillas Mine at the far end of the main drift represented by an intensely silicified volcanic breccia containing native silver and silver sulphides. The silver appears to have replaced the highly altered fragments within the host rock. The sample was taken from the footwall of a 3m wide highly mineralized quartz vein in the stoped area of the mine. The high-grade potential of Campanillas was first identified by a grab sample taken from a small stockpile outside the main portal, which returned an assay of 14.56 kg/t (14,560 g) silver and 15.53 g/t gold. The Company is currently putting a plan together for dewatering Campanillas in order to reach the second and possibly third level, which is accessed by a ramp and decline shaft. Once a better understanding of the mine can be developed, a drill plan will be proposed. There are almost 500m of historical workings on surface and along strike of the Campanillas Vein, represented by ventilation raises, trenches, and prospect pits, which indicate the minimum strike length of the structure.
Additional information on Auxico can be found on the Company’s website (www.auxicoresources.com) or on SEDAR (www.sedar.com) under “Auxico Resources Canada Inc.”
Technical information on the Zamora Property can be found in the Company’s Technical Report, dated August 16, 2017 (amended) and written by Joel Scodnick, P.Geo, an independent consultant to the Company.
Qualified Person
This news release was reviewed and approved by Joel Scodnick, P.Geo., an independent consultant to Auxico, in his capacity as a Qualified Person, as defined by National Instrument 43-101.
ON BEHALF OF THE BOARD OF DIRECTORS
« signed »
Mark Billings
President, Auxico Resources Canada Inc.
mb@auxicoresources.com
Cell: +1 514 296 1641
About Auxico Resources Canada Inc.
Auxico Resources Canada Inc. (“Auxico”) is a Canadian company that was founded in 2014 and based in Montreal. Auxico is engaged in the acquisition, exploration and development of mineral properties in Mexico. The Company has a 100{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} interest in the Zamora Silver-Gold Property in Sinaloa, Mexico. Auxico will continue to identify and potentially acquire additional property interests and conduct exploration and evaluation of these properties to assess their potential.
The Canadian Securities Exchange (CSE) has not reviewed and does not accept responsibility for the adequacy or the accuracy of the contents of this release.
- Published in Auxico Resources, Mining, News Home
Defiance Commences 5000 Metre Drill Program Targeting New Silver Shoots
Momentum Public Relations
Press Release: October 31, 2017
Vancouver, British Columbia–(Newsfile Corp. – October 31, 2017) – Defiance Silver Corp. (TSXV: DEF) (OTC: DNCVF) (“Defiance”) is pleased to announce the commencement of a Phase II, 5,000 meter drill program targeting new high-grade silver shoots along a 900m section of the Veta Grande vein located southeast of the San Acacio Silver Deposit in Zacatecas, Mexico.
“We are excited to begin the first systematic drill program testing the Veta Grande vein east of San Acacio. Our geological model indicates that with the Veta Grande tilting to the south east, historic miners did not recognize the potential of the vein along strike. If our model is correct, we could dramatically expand the district’s silver footprint. With two diamond drills operating, we look forward to a steady flow of drill results over the next three months.” stated Roy Bonnell, President and CEO of Defiance Silver Corp.
The Veta Grande vein, which pinches and swells along strike, produced approximately 200M ounces of silver from high-grade shoots in the swells, with an estimated 100M ounces of silver from high-grade shoots on Defiance’s portion of the Veta Grande. Mapping, mineralogical studies and drilling to date indicate that the pinching and swelling continues along strike and the mineralized system hosting the San Acacio deposit is tilted to the southeast. With only a few shallow historic exploration shafts and minor modern exploration, there is significant potential for the discovery of multiple intact, high grade silver shoots in this area. Over 4.4 km of Defiance’s 5.6 km holdings along the Veta Grande vein have not seen historical production nor been systematically explored, providing Defiance the opportunity to potentially grow the resource along strike.
A Panoramic Video on the San Acacio Deposit is available on our website, or Click Here to visit our Defiance YouTube Channel. Defiance Silver Corp. is a silver explorer and developer advancing the San Acacio Deposit, located in the historic Zacatecas Silver District of central Mexico. Defiance is managed by a team of proven mine developers with a track record of exploring and developing 7 operating mines to date. Defiance’s corporate mandate is to expand San Acacio to become one of Mexico’s premier high grade wide vein silver deposits.
Mr. Bruce Winfield, P.Geo. consultant to Defiance Silver Corp, is a Qualified Person within the meaning of National Instrument 43-101, and has approved the technical information concerning the Company’s material mineral properties contained in this press release.
On behalf of Defiance Silver Corp.
“Roy Bonnell“
President and CEO
For more information, please contact: Sunny Pannu – Corporate Development (604) 669 7315 or via email at pannu@defiancesilver.com
2300 – 1177 West Hastings Street
Vancouver, BC V6E 2K3
www.defiancesilver.com
Tel: 604-669-7315
Email:info@defiancesilver.com
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
- Published in Defiance Silver, Mining, News Home
Relevium Files and Provides Comments on the Audited Consolidated Financial Statements
Momentum Public Relations
Press Release: October 31, 2017
MONTREAL, QUEBEC–(Marketwired – Oct. 31, 2017) – Relevium Technologies Inc. (TSX VENTURE:RLV)(FRANKFURT:6BX) (the “Company” or “Relevium”), a publicly traded corporation strategically focused on creating value through the acquisition and development of e-brands, online businesses and e-retail technologies in the Health and Wellness space, is pleased to announce the filing of the company’s Audited Financial Statements and MD&A for the fiscal year ended June 30, 2017 and 2016 on Sedar
News Release Highlights
- An active year focused on acquisitions and its impact on the income statement
- Impact of Bioganix and first quarter of the fiscal year ending June 30, 2018
- Major events impacting our Consolidated Statements of Financial Position
An active fiscal year focused on acquisitions
The fiscal year ended June 30, 2017 was a year dedicated to the identification, evaluation and negotiation with several acquisition targets. As the Audited Consolidated Financial Statements and MD&A reveal, the company’s expenses increased substantially for the fiscal year ended June 30, 2017, primarily the result of the non-cash impairment of the carrying value of the intellectual assets acquired as part of the company’s qualifying transaction in 2015, totaling $747,322. The additional increase in expenses of $567,677 in consulting fees were related primarily to acquisitions and related expenses. The combination of these major categories of expenses resulted in a net and comprehensive loss of $2,584,738 as compared to $1,557,719 in 2016.
Commenting on the results for the reporting period, Aurelio Useche, President and CEO stated: “It was a year dedicated to the execution of our first acquisition in our roll-up strategy. The process was challenging but effective”. Mr Useche added: “The impact from operations of newly acquired Bioganix will only take effect in the company’s Consolidated Financial Statements for the three-month period ended September 30, 2017 (Q1), which will be reported at the end of this month of November”
Major events impacting our Consolidated Statements of Financial Position
The Company reported significant changes to the Consolidated Statements of Financial Position, including an increase in total assets of $6,111,470 from $1,003,682 in 2016 to $7,115,152 in 2017. In parallel, the Company also reported significant changes in total liabilities of $4,343,533, from $447,031 in 2016 to $4,790,564 in 2017. Most of these changes transpired during the last quarter of the fiscal year ended June 30, 2017 and were primarily the result of an equity financing, a debenture financing and the execution of the definitive agreement and deposit to acquire BioGanix.
Commenting on these major events, Aurelio Useche, President and CEO stated: “From the execution of the binding agreement to the close of all three major events six months later, the company’s overall financial position has improved materially, positioning Relevium to continue to execute on the roll-up strategy”. Mr Useche added: “Relevium remains an entrepreneurial venture at heart and every single person in the team, from directors to the actual operators of the business, is guided by this principle in mind: We are Intense, Nimble and Lean”
The company looks forward to continuing to update shareholders.
About Relevium Technologies
Relevium is a TSXV listed company focused on growth through the acquisition of businesses, products and/or technologies with a focus on e-commerce in the growing health and wellness sector. Relevium Technologies Inc. also holds patented intellectual property for the use of static magnetic fields for application on wearable devices.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cautionary Note Regarding Forward-Looking Statements
This press release may contain forward-looking information within the meaning of applicable securities legislation, which reflects the Company’s current expectations regarding future events. Forward-looking information is based on several assumptions and is subject to several risks and uncertainties, many of which are beyond the Company’s control that could cause actual results and events to differ materially from those that are disclosed in or implied by such forward-looking information. Readers should not place undue reliance on forward- looking statements and forward-looking information and are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake any obligation to update such forward-looking information, whether because of new information, future events or otherwise, except as expressly required by applicable law.
On Behalf of the Board of Directors
RELEVIUM TECHNOLOGIES INC.
Aurelio Useche, President and CEO
RELEVIUM TECHNOLOGIES INC
Edward Ierfino
Manager, Investor Relations
Tel: (514) 562-1374
Email: eierfino@releviumcorp.com
Website: www.releviumtechnologies.com
- Published in News Home, Nutraceutical, Relevium Technologies
Sirona Biochem Announces Resignation of Board Director
Momentum Public Relations
Press Release: October 27, 2017
VANCOUVER, BC–(Marketwired – October 27, 2017) – Sirona Biochem Corp. (TSX VENTURE: SBM) (FRANKFURT: ZSB)(XETRA: ZSB) announced today the resignation of Mr. David Moore from the board of directors due to conflicting commitments.
“We are very thankful to Mr. Moore for his contributions and guidance during his time on our board and wish him much success in his new position,” said Dr. Howard Verrico, CEO. “At this time the Company will remain with a vacancy on the board until a suitable replacement is found.”
About Sirona Biochem Corp.
Sirona Biochem is a cosmetic ingredient and drug discovery company with a proprietary platform technology. Sirona specializes in stabilizing carbohydrate molecules with the goal of improving efficacy and safety. New compounds are patented for maximum revenue potential.
Sirona’s compounds are licensed to leading companies around the world in return for licensing fees, milestone fees and ongoing royalty payments. Sirona’s laboratory, TFChem, is located in France and is the recipient of multiple French national scientific awards and European Union and French government grants. For more information, please visit www.sironabiochem.com.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Sirona Biochem cautions you that statements included in this press release that are not a description of historical facts may be forward-looking statements. Forward-looking statements are only predictions based upon current expectations and involve known and unknown risks and uncertainties. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of release of the relevant information, unless explicitly stated otherwise. Actual results, performance or achievement could differ materially from those expressed in, or implied by, Sirona Biochem’s forward-looking statements due to the risks and uncertainties inherent in Sirona Biochem’s business including, without limitation, statements about: the progress and timing of its clinical trials; difficulties or delays in development, testing, obtaining regulatory approval, producing and marketing its products; unexpected adverse side effects or inadequate therapeutic efficacy of its products that could delay or prevent product development or commercialization; the scope and validity of patent protection for its products; competition from other pharmaceutical or biotechnology companies; and its ability to obtain additional financing to support its operations. Sirona Biochem does not assume any obligation to update any forward-looking statements except as required by law.
For more information regarding this press release, contact:
Christopher Hopton, CFO
Sirona Biochem Corp.
Phone: 1.604.282.6064
Email: chopton@sironabiochem.com
- Published in Bio technology, Life Sciences, News Home, Sirona Biochem
Relevium Provides Operational Progress Update and Appoints Senior Marketing Officer
Momentum Public Relations
Press Release: October 27, 2017
MONTREAL, QUEBEC–(Marketwired – Oct. 27, 2017) – Relevium Technologies Inc. (TSX VENTURE:RLV)(FRANKFURT:6BX) (the “Company” or “Relevium”), a publicly traded corporation strategically focused on creating value through the acquisition and development of e-brands, online businesses and e-retail technologies in the Health and Wellness space, is pleased to announce a brief operational update on progress and the appointment of a Senior Marketing Officer.
News Release Highlights
- RLV appoints Senior Marketing Officer
- BioGanix and General Progress Update
- Financial reporting
Appointment of Senior Marketing Officer
Relevium Technologies is pleased to announce it has appointed Abis Hussain as the company’s Senior Marketing Officer, overseeing the company’s overall marketing and branding activities for its current and future portfolio of e-brands.
Mr. Hussain has been actively engaged in the e-marketing space since 2007 and most recently was Director of Influencer Marketing, as well as, Director of Online Marketing at RhythmOne, a global leader in providing streamlined, transparent connections between advertisers and audiences through a combination of differentiated supply, innovative technology and data-driven insights.
While at RhythmOne, Mr. Hussain expanded client communities and focused in locating target audiences by building social media strategies in the United States and Europe. Mr. Hussain was instrumental in increasing brand awareness by 50{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} for various brands and companies including Subaru, Nestle and Kellogg’s and has worked with pro-athletes and influencers on behalf of clients.
Aurelio Useche, CEO of Relevium Technologies stated: ” Abis has a wealth of knowledge in the business of driving internet traffic from sources outside the Amazon ecosystem. Mr. Useche stated further: “The skillset that Abis brings to the table is extremely complimentary to the existing expertise of the operations team which is very Amazon-centric as it stands. Abis has already demonstrated himself as a strong leader and has kicked off great initiatives that will positively impact the performance of our business.”
Business Update
The acquisition of BioGanix has been a successful endeavor for Relevium and for its shareholders. Revenues have continued to grow by an average of 50{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} versus the same period in 2016 and our customer base continues to expand.
Since July, the Company has been focused on the optimization of the BioGanix brand through internal efforts and through new products and brand extensions. The BioGanix brand continues to expand with the soft launch of four new SKUs in November. The customer and revenues base are expected to continue to grow organically and as planned.
Shareholders can look forward to detailed information about the results from BioGanix for the three-month period ended September 30, 2017 on its first quarter filings due at the end of November 2017.
Shareholders should also be mindful that the financial impact of the operations of the BioGanix brand will not be part of the Audited Financials for the fiscal year ended June 30, 2017, which are due at the end of this month.
The Company’s CEO expects to hold a call for shareholders at the end of November in order to discuss first quarter performance and provide shareholders with an overview of progress and future strategy. Details will be provided in a subsequent press release.
About Relevium Technologies
Relevium is a TSXV listed company focused on growth through the acquisition of businesses, products and/or technologies with a focus on e-commerce in the growing health and wellness sector. Relevium Technologies Inc. also holds patented intellectual property for the use of static magnetic fields for application on wearable devices.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cautionary Note Regarding Forward-Looking Statements
This press release may contain forward-looking information within the meaning of applicable securities legislation, which reflects the Company’s current expectations regarding future events. Forward-looking information is based on several assumptions and is subject to several risks and uncertainties, many of which are beyond the Company’s control that could cause actual results and events to differ materially from those that are disclosed in or implied by such forward-looking information. Readers should not place undue reliance on forward- looking statements and forward-looking information and are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake any obligation to update such forward-looking information, whether because of new information, future events or otherwise, except as expressly required by applicable law.
On Behalf of the Board of Directors
RELEVIUM TECHNOLOGIES INC.
Aurelio Useche, President and CEO
RELEVIUM TECHNOLOGIES INC
Edward Ierfino
Manager, Investor Relations
Tel: (514) 562-1374
Email: eierfino@releviumcorp.com
Website: www.releviumtechnologies.com
- Published in News Home, Nutraceutical, Relevium Technologies, Technology
Puma Exploration Welcomes Denis Amoroso as Strategic Adviser to the board
Momentum Public Relations
Press Release: October 27, 2017
RIMOUSKI, QUEBEC–(Marketwired – Oct. 27, 2017) – Puma Exploration Inc. (the “Company” or “Puma”) (TSX VENTURE:PUM)(SSE:PUMA) welcomes Denis Amoroso as Financial and Strategic adviser to the board of the Company. Mr. Amoroso has been in the brokerage and financial business for thirty-seven years, including 25 years as Senior Adviser at Canaccord Genuity. He was Canadian member of the Chairman’s Club and member of the president’s Club nine times.
A pillar in the mining sector, focusing on Quebec junior exploration companies, he raised more than $100 million over the last 30 years. He has participated in the funding of more than forty Junior Companies, starting from the exploration stage to development and finally to mining producers. “His vast knowledge of the financial sector and his contacts make him an invaluable resource for Puma Exploration, particularly in our current stage of developing the Murray Brook Project, in the Bathurst Mining Camp.” Note Marcel Robillard, President of Puma Exploration.
Murray Brook Deposit (Bathurst Mining Camp)
The underground sulphide mineral resource estimate of the Murray Brook Deposit comprises measured and indicated mineral resources totalling 5.28 million tonnes averaging 5.24 per cent zinc, 1.80 per cent lead, 0.46 per cent copper, 68.9 grams per tonne silver and 0.65 g/t gold. It contains 610 million pounds of zinc, 209 million pounds of lead, 54 million pounds of copper, 11.7 million ounces of silver and 111,000 ounces of gold at a $85 per-tonne NSR (net-smelter-return) cut-off in the sulphide measured and indicated categories. On February 20th 2017, the NI 43-101 report was accepted and filed on SEDAR.
Puma is updating the PEA on the Murray Brook Deposit. Various economic and development scenarios are currently studied, from a large open pit to a high grade zinc underground operation.
About the Murray Brook Project
The Murray Brook Project consists of three (3) distinct contiguous areas that cover more than 18 kilometers of the favorable rock hosting the operating Caribou Mine (Trevali Mining Corp.), the Murray Brook Deposit and the past operating Restigouche Mine (Trevali Mining Corp.). From east to west, they are the Murray Brook East Property (4925), the Murray Brook Mining Lease (# 252) and the Murray Brook West Property (7846). The Murray Brook East and Murray Brook West Properties have been subject to various degrees of exploration and share the same potential of increasing the mineral resources defined at the Murray Brook Deposit.
About Puma Exploration Inc.
Puma Exploration is a Canadian mineral exploration company with advanced precious and base metals projects in Canada. The Company’s major assets are an option to acquire 100{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} per-cent beneficial interest in the Murray Brook Property, the Turgeon Zinc-Copper Project and the Nicholas-Denys Project located in New Brunswick as well as an equity interest in BWR Resources. Puma’s objective for the coming year is to focus its exploration efforts in New Brunswick.
You can visit us on Facebook and Twitter.
Learn more by consulting www.pumaexploration.com for further information on Puma Exploration Inc.
The contents of this press release were prepared by Marcel Robillard, P.Geo., a Qualified Person as defined in NI 43-101. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements: This press release may contain forward-looking statements. Such forward-looking statements involve a number of known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Puma Exploration Inc. to be materially different from actual future results and achievements expressed or implied by such forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements which speak only as of the date the statements were made, except as required by law. Puma Exploration undertakes no obligation to publicly update or revise any forward-looking statements. These risks and uncertainties are described in the quarterly and annual reports and in the documents submitted to the securities administration.
Marcel Robillard, President
(418) 724-0901
president@explorationpuma.com
- Published in Mining, News Home, Puma Exploration
Arctic Star arranges $1.5-million private placement
Momentum Public Relations
Press Release: October 26, 2017
2017-10-26 12:58 ET – News Release
Mr. Patrick Power reports
ARCTIC STAR ANNOUNCES NON-BROKERED PRIVATE PLACEMENT
Arctic Star Exploration Corp. has arranged a non-brokered private placement of up to 15 million units at a price of 10 cents per unit, for gross proceeds of up to $1.5-million. Each unit will comprise one common share in the capital of the company and one non-transferable share purchase warrant. Each warrant will entitle the holder to purchase one additional share in the capital of the company for a period of 24 months from the closing date at an exercise price of 15 cents.
All securities will be subject to a four-month hold period from the closing date. The private placement is subject to TSX Venture Exchange approval.
Finders’ fees may be paid in accordance with TSX-V policies.
The company intends to use the proceeds from the private placement for exploration on the Foriet diamond property and for general working capital.
We seek Safe Harbor.
© 2017 Canjex Publishing Ltd. All rights reserved.
- Published in Arctic Star Exploration, Mining, News Home
Sirona Biochem Announces Close of Oversubscribed Private Placement
Momentum Public Relations
Press Release: October 26, 2017
VANCOUVER, BC–(Marketwired – October 26, 2017) – Sirona Biochem Corp. (TSX VENTURE: SBM) (FRANKFURT: ZSB)(XETRA: ZSB) (the “Company“) announced today that it has closed an oversubscribed, non-brokered private placement for gross proceeds of $635,000. The private placement consists of 4,233,333 units, (the “Units”) at a price of $0.15 per Unit. Each Unit consists of one common share and one transferable share purchase warrant, each whole warrant exercisable into one additional common share of the Company for a period of 2 years from the date of issue at a price of $0.25 per share.
Dr. Howard Verrico, CEO, has participated in the Private Placement with the purchase of 1,000,000 Units and upon completion, owns 5,951,250 common shares.
All securities issued under the placement are subject to statutory hold periods expiring on February 26, 2018.
Proceeds of the placement will be used for general working capital.
About Sirona Biochem Corp.
Sirona Biochem is a cosmetic ingredient and drug discovery company with a proprietary platform technology. Sirona specializes in stabilizing carbohydrate molecules with the goal of improving efficacy and safety. New compounds are patented for maximum revenue potential.
Sirona’s compounds are licensed to leading companies around the world in return for licensing fees, milestone fees and ongoing royalty payments. Sirona’s laboratory, TFChem, is located in France and is the recipient of multiple French national scientific awards and European Union and French government grants. For more information please visit www.sironabiochem.com.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Sirona Biochem cautions you that statements included in this press release that are not a description of historical facts may be forward-looking statements. Forward-looking statements are only predictions based upon current expectations and involve known and unknown risks and uncertainties. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of release of the relevant information, unless explicitly stated otherwise. Actual results, performance or achievement could differ materially from those expressed in, or implied by, Sirona Biochem’s forward-looking statements due to the risks and uncertainties inherent in Sirona Biochem’s business including, without limitation, statements about: the progress and timing of its clinical trials; difficulties or delays in development, testing, obtaining regulatory approval, producing and marketing its products; unexpected adverse side effects or inadequate therapeutic efficacy of its products that could delay or prevent product development or commercialization; the scope and validity of patent protection for its products; competition from other pharmaceutical or biotechnology companies; and its ability to obtain additional financing to support its operations. Sirona Biochem does not assume any obligation to update any forward-looking statements except as required by law.
For more information regarding this press release, please contact:
Christopher Hopton
CFO
Sirona Biochem Corp.
Phone: 1.604.282.6064
Email: chopton@sironabiochem.com
- Published in Bio technology, News Home, Sirona Biochem